drugset / Trial / NCT02058264
A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine the safety, tolerability, pharmacokinetics and treatment effect of BBI-4000 when topically applied to subjects with axillary hyperhidrosis.
Timeline
- Start
- 2014-02
- Primary completion
- 2014-08
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SOFPIRONIUM | Small molecule | — | Topical |
Indications
No indication recorded.